MARTIN M II COYNE
CIK 1187040 · last filed 2015-03-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.05M
Companies
2
Total Filings
27
Lifetime Open-Market Net
-$3.67M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AKAM | Director | 37,861 | $133.50 | $5.05M | -$3.67M | 24 | 2015-03-26 |
| BIOCLINICA INC (BIOC) Delisted | Director | 0 | $0.43 | $0 | $0 | 3 | 2013-03-14 |
Recent Filings · Page 2 of 3
27 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-05-17 | BIOCLINICA INC (BIOC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-03-15 | AKAM | Mixed | — | -$394.8K | EDGAR |
| 2012-02-23 | AKAM | Mixed | — | -$414.0K | EDGAR |
| 2011-05-19 | AKAM | Grant (A) | — | $0 | EDGAR |
| 2011-05-13 | BIOCLINICA INC (BIOC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-11-10 | AKAM | Mixed | — | -$117.0K | EDGAR |
| 2010-10-12 | AKAM | Mixed | — | -$199.5K | EDGAR |
| 2010-09-15 | AKAM | Mixed | — | -$227.3K | EDGAR |
| 2010-08-20 | AKAM | Mixed | — | -$199.5K | EDGAR |
| 2010-05-26 | AKAM | Exer (M) | +4,261 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.